Stimulatory Effects of Tolbutamide Infusion on Plasma Glucagon in Insulin-Dependent Diabetic Subjects*
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The effect of iv tolbutamide on endogenous glucagon levels was measured in nine insulin-dependent diabetic patients chosen because they evidenced no C-peptide response to beta-cell secretagogues. Basal glucagon levels were not suppressed by a sustained tolbutamide infusion; in fact, a slight stimulatory effect was observed at 5, 10, 30, and 45 min. In the absence of detectable insulin secretory capacity and suboptimal insulin replacement, tolbutamide appears to be a stimulus, not a suppressant, of glucagon secretion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stimulation of Glucagon Secretion by Epinephrine in Man
GERICH, J. E., KARAM, J. H., & FORSHAM, P. H. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-3-479 · Cited by 164
Self-citation
Cited by
α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Gromada, J., Franklin, I., & Wollheim, C. B. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0007 · Cited by 581
Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes
Quesada, I., Tudurí, E., Ripoll, C., & Nadal, Á. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0290 · Cited by 412
Franklin, I., Gromada, J., Gjinovci, A., Theander, S., & Wollheim, C. B. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1808 · Cited by 299
Regulation of glucagon secretion by glucose: paracrine, intrinsic or both?
Walker, J. N., Ramracheya, R., Zhang, Q., Johnson, P. R. V., Braun, M., & Rorsman, P. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01450.x · Cited by 176
“Given that glucagon secretion is under the control of KATPchannel and that tolbutamide inhibits glucagon secretion from isolated islets from both rodent and human islets [48], it may seem surprising that sulphonylureas therapy does not correct the hypersecretion of glucagon in type-1 diabetes [31]; sulphonylureas have…”
BackgroundOlsen, H. L., Theander, S., Bokvist, K., Buschard, K., Wollheim, C. B., & Gromada, J. (2005) · Endocrinology · doi:10.1210/en.2005-0800 · Cited by 156
Marks, V., & Teale, J. D. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70088-8 · Cited by 150
Pedersen, M. G., Ahlstedt, I., El Hachmane, M. F., & Göpel, S. O. (2016) · Scientific Reports · doi:10.1038/srep31214 · Cited by 64
“For example sulfonylureas have been reported to increase, decrease and to have no effect on secretion 15,42–44 .”
ter Braak, E. W. M. T., Appelman, A. M. M. F., van der Tweel, I., Erkelens, D. W., & van Haeften, T. W. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.107 · Cited by 40
“A direct effect of the SU on the -cell is less likely, because KATP channel blockers per se are expected to stimulate (rather than inhibit) glucagon release (16).”
BackgroundA computational systems analysis of factors regulating α cell glucagon secretion
Fridlyand, L. E., & Philipson, L. H. (2012) · Islets · doi:10.4161/isl.22193 · Cited by 12
Metadata
- Authors
- BOHANNON, N. V., LORENZI, M., GRODSKY, G. M., & KARAM, J. H.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1982-02
- Volume
- 54
- Issue
- 2
- Pages
- 459-462
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2032900229
- Cited by
- 27
- References
- 1
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.